Inder Anand

Dr. Anand received his Ph.D. degree in cardiovascular physiology from Oxford University and is a professor at the University of Minnesota. He is the chairman of the heart failure group. He is an advisor for global clinical trials for Neucardin™. He has been active in designing and conducting clinical trials in heart failure over the last twenty years. He has been a principal investigator in over 50 heart failure clinical trials, and a member of steering and end-point committees on several of these international trials. He is a member of the editorial board for several scientific journals and has authored over 300 publications with over 1,000 citations of his published work.